NEW YORK, June 18, 2018 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Catalyst Biosciences, Inc. (“Catalyst” or the “Company”)
CBIO, -60.40%
Such investors are advised to contact Robert S. …
Go to Source